{"log_id": 3817387688422326769, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 3e-06, "average": 0.998978, "min": 0.991793}, "location": {"width": 554, "top": 230, "height": 26, "left": 253}, "words": "神经阻滞剂,阿片类及含利血平的抗高血压药可抑制本品的作用"}, {"probability": {"variance": 3.9e-05, "average": 0.997065, "min": 0.964754}, "location": {"width": 740, "top": 291, "height": 26, "left": 254}, "words": "当要给接受不可逆的非选择性单胺氧化酶抑制剂的患者服用本品时,则应在开始服用本"}, {"probability": {"variance": 4.7e-05, "average": 0.996469, "min": 0.971405}, "location": {"width": 780, "top": 336, "height": 29, "left": 213}, "words": "品前停用单胺氧化酶抑制药至少两周,否则可能会发生像高血压危象等不良反应(见【禁"}, {"probability": {"variance": 0.003401, "average": 0.983887, "min": 0.642653}, "location": {"width": 779, "top": 382, "height": 28, "left": 213}, "words": "忌】)。然而,已接受本品治疗的患者可使用选择性单胺氧化酶B抑制剂(如司来吉兰和雷沙"}, {"probability": {"variance": 0.00016, "average": 0.994418, "min": 0.94352}, "location": {"width": 780, "top": 428, "height": 26, "left": 213}, "words": "吉兰)和选择性单胺氧化酶A抑制剂(如吗氯贝胺),这时建议根据每个患者的疗效和耐受"}, {"probability": {"variance": 0.000375, "average": 0.992776, "min": 0.888226}, "location": {"width": 781, "top": 472, "height": 26, "left": 212}, "words": "情况调节左旋多巴的剂量。合用单胺氧化酶A与单胺氧化酶B抑制剂相当于服用非选择性"}, {"probability": {"variance": 0.000103, "average": 0.994607, "min": 0.962459}, "location": {"width": 514, "top": 517, "height": 27, "left": 214}, "words": "单胺氧化酶抑制剂,因而不应与本品联合使用(见【禁忌】)"}, {"probability": {"variance": 0.001494, "average": 0.990135, "min": 0.771269}, "location": {"width": 739, "top": 577, "height": 28, "left": 254}, "words": "本品不可与拟交感神经类药物(如兴奋交感神经系统的肾上腺素、去甲肾上腺素,异丙"}, {"probability": {"variance": 0.002155, "average": 0.986084, "min": 0.77771}, "location": {"width": 780, "top": 624, "height": 33, "left": 213}, "words": "肾上腺素或苯丙胺等)同时使用,因为左旋多巴能使这些药物的作用增强。必须同时"}, {"probability": {"variance": 0.006983, "average": 0.977205, "min": 0.510861}, "location": {"width": 697, "top": 668, "height": 32, "left": 212}, "words": "使用这类药物,则应严密监测心血管系统反应并需减少拟交感神经类药物的用量。"}, {"probability": {"variance": 0.020269, "average": 0.939397, "min": 0.535187}, "location": {"width": 741, "top": 722, "height": 44, "left": 253}, "words": "本品可与其他抗帕金森病药物(如抗胆碱能药物、金刚烷吉兰、溴隐二利家"}, {"probability": {"variance": 0.003958, "average": 0.983707, "min": 0.626266}, "location": {"width": 716, "top": 774, "height": 27, "left": 212}, "words": "胺受体激动剂等)联合使用,尽管治疗作用和不良反应可能同时在联合使用时"}, {"probability": {"variance": 0.001479, "average": 0.986967, "min": 0.794208}, "location": {"width": 780, "top": 816, "height": 31, "left": 212}, "words": "本品或其他药物的用量当开始使用COMT抑制剂进行辅助治疗时本品的剂量应该当下"}, {"probability": {"variance": 3e-06, "average": 0.998769, "min": 0.993507}, "location": {"width": 695, "top": 864, "height": 28, "left": 212}, "words": "调。由于左旋多巴在短时间内尚不能产生疗效,因此不能骤然停用抗胆碱能药物"}, {"probability": {"variance": 4.8e-05, "average": 0.996955, "min": 0.969114}, "location": {"width": 739, "top": 924, "height": 27, "left": 254}, "words": "左旋多巴可影响儿茶酚胺类、肌酐、尿酸以及血糖的化验结果。尿检结果酮体可呈假阳"}, {"probability": {"variance": 0, "average": 0.99997, "min": 0.99997}, "location": {"width": 24, "top": 973, "height": 24, "left": 213}, "words": "性"}, {"probability": {"variance": 0.002291, "average": 0.985268, "min": 0.778638}, "location": {"width": 447, "top": 1032, "height": 27, "left": 254}, "words": "使用本品的患者中, Coombs试验可能呈假阳性结果"}, {"probability": {"variance": 4e-06, "average": 0.998296, "min": 0.993595}, "location": {"width": 298, "top": 1092, "height": 26, "left": 254}, "words": "同时进食高蛋白膳食会使药效下降"}, {"probability": {"variance": 0.000314, "average": 0.994317, "min": 0.893335}, "location": {"width": 739, "top": 1151, "height": 27, "left": 254}, "words": "与可阻断多巴胺受体的抗精神病类药物合并给药,特别是D2受体阻断剂,可能会对多"}, {"probability": {"variance": 0.001938, "average": 0.988349, "min": 0.759543}, "location": {"width": 765, "top": 1197, "height": 26, "left": 215}, "words": "巴丝肼抗帕金森病治疗效果产生拮抗作用。左旋多巴可能会减弱这些药物的抗精神病效果"}, {"probability": {"variance": 0.001479, "average": 0.986511, "min": 0.85952}, "location": {"width": 259, "top": 1242, "height": 25, "left": 215}, "words": "与此类药物合并给药时需慎"}, {"probability": {"variance": 0.077785, "average": 0.778525, "min": 0.384445}, "location": {"width": 114, "top": 1246, "height": 51, "left": 901}, "words": "股份"}, {"probability": {"variance": 0.003655, "average": 0.982165, "min": 0.634364}, "location": {"width": 740, "top": 1299, "height": 31, "left": 253}, "words": "采用氟烷进行全身麻醉:由于氟烷可能引起血压波动和/或心律失常,如需采用氟烷进"}, {"probability": {"variance": 8.2e-05, "average": 0.996867, "min": 0.957585}, "location": {"width": 375, "top": 1348, "height": 25, "left": 214}, "words": "行全身麻醉,应在术前1248小时停药本品"}, {"probability": {"variance": 0, "average": 0.780038, "min": 0.780038}, "location": {"width": 66, "top": 1327, "height": 60, "left": 930}, "words": "★"}, {"probability": {"variance": 0.001093, "average": 0.991605, "min": 0.833285}, "location": {"width": 470, "top": 1406, "height": 27, "left": 254}, "words": "如果使用其他麻醉剂进行全身麻醉,参见【注意事项】"}, {"probability": {"variance": 1e-06, "average": 0.998846, "min": 0.99697}, "location": {"width": 111, "top": 1453, "height": 25, "left": 220}, "words": "【药物过量】"}, {"probability": {"variance": 0, "average": 0.999802, "min": 0.999454}, "location": {"width": 103, "top": 1500, "height": 23, "left": 217}, "words": "症状及体征"}, {"probability": {"variance": 0.005982, "average": 0.946051, "min": 0.799206}, "location": {"width": 120, "top": 1569, "height": 23, "left": 544}, "words": "第7页/共11页"}], "language": 3}